ARCHIVES

Legal experts say too many conflicts involved. HHS gave von Eschenbach a waiver for his role in C-Change.

This article is from The Cancer Letter archive.

Vol. 31 No. 35 | September 30, 2005

Download PDF Visit The Full Archive

Related Articles

FDA Delays Decision On Avastin Approval For Breast Cancer

September 24, 2010

Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says

September 26, 2014

ONF Offer Grants

February 9, 1996

Sloan-Kettering Sues Empire Blue Cross Over Reimbursement

September 17, 1993

Contracts Cutback Canceled 7 RFPs

August 8, 1980

Information Branches Combined Under ICIC, Moved to Office Of NCI Deputy Director

November 23, 1997